Records containing: Parkinson's Disease
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-11-09A Post Market Clinical Evaluation of Deep Brain Stimulation as an Adjunctive Treatment for Reducing Some of the Symptoms of Advanced, Levodopa-responsive Parkinson's Disease That Are Not Adequately Controlled With Medication
-
CLINICAL_TRIALS study record update · 2022-11-03Ongoing, Web-Based Genome-Wide Association Studies for Targeted Disease Initiatives
-
CLINICAL_TRIALS study record update · 2022-10-31Caloric Vestibular Stimulation in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2022-10-28The Precise Transplantation of Human Amniotic Epithelial Stem Cells Into the Ventricle Through Surgical Robot in the Treatment of Parkinson's Disease.
-
CLINICAL_TRIALS study record update · 2022-10-14Dopamine Buffering Capacity Measured by phMRI as a Novel Biomarker of Disease Progression in PD
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-10-12Physical Activity Behavior and Health-Related Quality of Life in Parkinson's Disease Patients: Role of Social Cognitive Variables
-
CLINICAL_TRIALS study record update · 2022-09-16Effects of Exenatide on Motor Function and the Brain
-
CLINICAL_TRIALS study record update · 2022-08-15MRI-guided Personalized Targeting of the Ventral Intermediate Nucleus (VIM)/Dentato-rubro-thalamic Tract (DRT) for the MRgFUS Tremor Treatment
-
CLINICAL_TRIALS study record update · 2022-08-12Acute Effects of Medium Chain Triglyceride (MCT) Nutritional Ketosis on Parkinson s Disease (PD) Symptoms and Biomarkers (MCT-PD)
-
CLINICAL_TRIALS study record update · 2022-08-10Assessing the Pharmacokinetics, Safety, Tolerability and Efficacy of Continuous Oral Levodopa Via the DopaFuse® Delivery System in Parkinson's Disease Patients
-
CLINICAL_TRIALS study record update · 2022-08-08Telehealth Psychotherapy for Depression in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2022-07-29Pathophysiology of Neuronal Oscillations Within Subthalamo-cortical Loops in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2022-07-25Study on the Correlation Between MAPT Haploid H1b and the Damage of Blood-brain Barrier in Dorsal Medulla Oblongata and Autonomic Dysfunction in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2022-07-22Cutaneous Autonomic Pilomotor Testing to Unveil the Role of Neuropathy Progression in Early Parkinson's Disease (CAPTURE PD)
-
CLINICAL_TRIALS study record update · 2022-06-10Effects of Probiotics on Peripheral Immunity in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2022-06-09A Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of MEDI1341 in Healthy Male and Female Volunteers
-
CLINICAL_TRIALS study record update · 2022-06-03A Randomized, Double-blind, Placebo-controlled Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Ascending Doses of MEDI1341 in Subjects With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2022-05-24A Phase IIa, Randomized, Multicenter, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of DA-9805 in Subjects With Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2022-05-12Innovative Biomarkers in de Novo Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2022-05-06Prospective Memory in Parkinson's Disease
-
CLINICAL_TRIALS study record update · 2022-05-03A Multicentre, Open-label Study to Determine the Long Term Safety, Tolerability and Efficacy of ProSavin in Patients With Bilateral, Idiopathic Parkinson's Disease.
-
CLINICAL_TRIALS study record update · 2022-05-03A Phase 2A Safety and Biomarker Study of EPI-589 in Mitochondrial Subtype and Idiopathic Parkinson's Disease Subjects
-
CLINICAL_TRIALS study record update · 2022-04-29A Phase 2a, Double-blind, Randomized, Placebo-controlled, Crossover Study to Evaluate the Safety and Efficacy of AVP-923 (Dextromethorphan/Quinidine) in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients.
-
CLINICAL_TRIALS study record update · 2022-04-25Phenylbutyrate Response As a Biomarker for Alpha-Synuclein Clearance From Brain
-
CLINICAL_TRIALS study record update · 2022-04-12Clinical Investigation of Transplantation of Neural Stem Cell-derived Neurons for the Treatment of Parkinson's Disease